Lb Pharmaceuticals Inc (LBRX)
Lb Pharmaceuticals stock today
Lb Pharmaceuticals closed at $39.70 on October 30, 2026, down 1.12% on the day. Over the past year it returned +143.9% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $1.14 billion.
| Period | LBRX | S&P 500 (SPY) |
|---|---|---|
| 1 month | +3.4% | -0.9% |
| 3 months | -2.9% | +2.1% |
| Year to date | +78.3% | +11.7% |
| 1 year | +143.9% | +12.4% |
Key statistics
- Market value
- $1.14B
- P/E (trailing)
- 1.7
- 52-week range
- $14.61 to $49.48
- Next report
- Nov 12, 2026 (estimated)
About Lb Pharmaceuticals
Pharmaceutical company developing and commercializing drug therapies.
Sector: Health Care
More on Lb Pharmaceuticals
- Valuation: P/E history and peersP/E 1.7
- Returns: what $1,000 became$1,000 one year ago is $2,439 today
No forecast, no recommendation. This page describes Lb Pharmaceuticals Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.